Know Labs (NYSEAMERICAN:KNW) Shares Up 3.8% – What’s Next?

Core Insights - Know Labs' stock price increased by 3.8%, reaching a last traded price of $2.1390, with a trading volume of 612,050 shares, which is 60% higher than the average session volume [6] - The company has a market capitalization of $16.04 million and a P/E ratio of -0.33, indicating it is currently not profitable [1] Company Overview - Know Labs, Inc. is a life sciences company that develops non-invasive sensing solutions using its proprietary Bio-RFID platform, which detects biochemical markers like blood glucose and hydration levels without invasive procedures [3] - The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways [4] Hedge Fund Activity - Several hedge funds have recently acquired stakes in Know Labs, with notable purchases including Cerity Partners LLC ($158,000), Corient Private Wealth LLC ($99,000), Bard Financial Services Inc. ($80,000), and United Capital Management of KS Inc. ($49,000) [2] - Hedge funds and other institutional investors own 23.96% of Know Labs' stock [2]